1. Home
  2. OXBR vs TNXP Comparison

OXBR vs TNXP Comparison

Compare OXBR & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXBR
  • TNXP
  • Stock Information
  • Founded
  • OXBR 2013
  • TNXP 2007
  • Country
  • OXBR Cayman Islands
  • TNXP United States
  • Employees
  • OXBR N/A
  • TNXP N/A
  • Industry
  • OXBR Property-Casualty Insurers
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • OXBR Finance
  • TNXP Health Care
  • Exchange
  • OXBR Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • OXBR 21.3M
  • TNXP 71.6M
  • IPO Year
  • OXBR 2014
  • TNXP N/A
  • Fundamental
  • Price
  • OXBR $3.15
  • TNXP $13.47
  • Analyst Decision
  • OXBR
  • TNXP Strong Buy
  • Analyst Count
  • OXBR 0
  • TNXP 1
  • Target Price
  • OXBR N/A
  • TNXP $1,100.00
  • AVG Volume (30 Days)
  • OXBR 39.6K
  • TNXP 1.6M
  • Earning Date
  • OXBR 03-25-2025
  • TNXP 03-31-2025
  • Dividend Yield
  • OXBR N/A
  • TNXP N/A
  • EPS Growth
  • OXBR N/A
  • TNXP N/A
  • EPS
  • OXBR N/A
  • TNXP N/A
  • Revenue
  • OXBR N/A
  • TNXP $11,291,000.00
  • Revenue This Year
  • OXBR N/A
  • TNXP $64.71
  • Revenue Next Year
  • OXBR N/A
  • TNXP $24.49
  • P/E Ratio
  • OXBR N/A
  • TNXP N/A
  • Revenue Growth
  • OXBR N/A
  • TNXP 183.05
  • 52 Week Low
  • OXBR $0.87
  • TNXP $6.76
  • 52 Week High
  • OXBR $5.81
  • TNXP $1,216.00
  • Technical
  • Relative Strength Index (RSI)
  • OXBR 33.58
  • TNXP 48.16
  • Support Level
  • OXBR $3.06
  • TNXP $6.76
  • Resistance Level
  • OXBR $3.48
  • TNXP $18.63
  • Average True Range (ATR)
  • OXBR 0.53
  • TNXP 1.91
  • MACD
  • OXBR -0.17
  • TNXP 1.28
  • Stochastic Oscillator
  • OXBR 7.96
  • TNXP 56.53

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: